Kidney Transplant Rejection
📧 Sign up to get email alerts when something new happens for Kidney Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients [Phase 1, Phase 2]
Phase 1/2 trial results assess safety and tolerability of a chimeric antigen receptor T-regulatory cell therapy in living donor renal transp…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) [Phase 3]
Phase 3 clinical trial evaluating the safety and effects of felzartamab infusions in adults with antibody-mediated rejection after kidney tr…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation [Phase 2, Phase 3]
A clinical trial comparing Frexalimab to Tacrolimus in adult kidney transplant recipients is in Phase 2/Phase 3 and currently recruiting, ev…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) [Phase 3]
A Phase 3 clinical trial updating on long-term safety and effects of felzartamab infusions in adults with kidney transplants experiencing an…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Bortezomib in Rejection of Kidney Transplants [Phase 2]
Phase 2 trial evaluating bortezomib for chronic antibody-mediated rejection in kidney transplants has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function [NA]
This clinical trial update describes the AIIM trial, which investigates a personalized medicine approach to kidney allograft function in kid…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Molecular HistoMx Assessment for Kidney Transplant Rejection and Management
This clinical trial evaluating Molecular HistoMx for detecting and managing kidney transplant rejection has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation [Phase 3]
A Phase 3 trial evaluating rituximab for progression of humoral acute rejection after kidney transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)
Long-term follow-up data on the investigational TX200-TR101 therapy (STEADFAST Long Term) evaluating outcomes in kidney transplant rejection…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR [Phase 4]
Phase 4 trial evaluating a simplified, low-dose tacrolimus (Envarsus XR) immunosuppressive protocol in kidney transplantation; the study sta…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation [Phase 2]
Phase 2 trial results for Tegoprubart in patients undergoing kidney transplantation, reporting safety and efficacy for preventing or treatin…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: PROACT Pilot Trial
An update on the PROACT Pilot Trial sponsored by the University of British Columbia to investigate treatment for kidney transplant rejection…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR
This is a long-term follow-up clinical trial evaluating kidney transplant patients treated with imlifidase or plasma exchange after antibody…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant [Phase 1, Phase 2]
The trial update reports Phase 1/2 results for clazakizumab in chronic and active antibody-mediated rejection after kidney transplantation, …
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Utilising Volumetric Absorptive Microsampling (VAMS) Technology to Monitor Tacrolimus and Creatinine
Clinical trial update on using Volumetric Absorptive Microsampling (VAMS) to monitor tacrolimus and creatinine in kidney transplant patients…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Improving KIdney Transplantation with Cellular Therapy Study
A study evaluating cellular therapy to improve kidney transplantation has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant [Phase 1, Phase 2]
Clinical trial update on clazakizumab for highly HLA-sensitized patients awaiting kidney transplant; the study spans Phase 1/2 with status A…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation
This clinical trial update presents results from a follow-up study of patients treated with imlifidase prior to kidney transplantation, eval…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection [NA]
A completed study from Charité University evaluated donor-derived cell-free DNA as an early diagnostic biomarker for antibody-mediated rejec…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore [NA]
A completed clinical trial evaluated whether achieving early target trough levels of tacrolimus using CYP3A5-guided dosing provides advantag…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: BIOtechnology Applied to Renal TRansplantation With IMmunobiogram
Completed clinical trial evaluating biotechnology applied to renal transplantation using Immunobiogram for kidney transplant failure and rej…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Impact of Microvascular Inflammation on Kidney Allograft Outcome
Completed clinical trial update assessing the impact of microvascular inflammation on kidney allograft outcomes.
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients [Phase 4]
Phase 4 trial comparing tacrolimus extended-release (Envarsus XR) to immediate-release tacrolimus in HLA-sensitized kidney transplant recipi…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants [Phase 3]
Phase 3 trial evaluating cellular immunotherapy in recipients of HLA-matched living-donor kidney transplants has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN
The EU-TRAIN study on precision risk stratification in kidney transplant patients has completed.